University of Strathclyde Background
DxCover are developing a multi-cancer platform powered by DxCover AI Engine, with the first application in earlier diagnosis of brain tumours. The DxCover platform combines novel hardware with artificial intelligence algorithms to analyse a patient’s blood and detect the presence or absence of disease.
DxCover platform: The DxCover platform combines novel hardware with artificial intelligence algorithms to analyse a patient’s blood and detect the presence or absence of disease.
Drop Dry Detect: A drop of blood serum is dried on a DxCover Slide and analysed with infrared light. Data is captured from all the vital components, including the body’s response to disease. The Artificial Intelligence algorithm provides a result in minutes.
Stage of Development
The team have successfully completed two groundbreaking studies on earlier diagnosis of brain cancer, and is currently developing its platform for the detection of commonly occurring cancers.
Applications include diagnostic tools & triaging, specifically for use on potential cancer patients.
Get ready to take your space management game to the next level with the University of Glasgow’s innovative project! By combining the